Compugen
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company's pipeline consists of COM701, an immuno-oncology pipeline program with an anti-PVRIG antibody; COM902, a therapeutic anti-TIGIT antibody, are in Phase 1 clinical tria… Read more
Compugen (CGEN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2022: -0.296x
Based on the latest financial reports, Compugen (CGEN) has a cash flow conversion efficiency ratio of -0.296x as of December 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-23.03 Million) by net assets ($77.68 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Compugen - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how Compugen's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Compugen Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Compugen ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wenzhou Yuanfei Pet Toy Products Co. Ltd. A
SHE:001222
|
0.030x |
|
Omai Gold Mines Corp
OTCQB:OMGGF
|
-0.077x |
|
Beijing North Star Company Limited
PINK:BEIJF
|
0.041x |
|
Avalo Therapeutics Inc
NASDAQ:AVTX
|
-0.179x |
|
CWB Automotive Electronics Co Ltd
SHG:605005
|
0.057x |
|
Eczacibasi Yatirim Holding Ortakligi AS
IS:ECZYT
|
0.001x |
|
China General Plastics Corp
TW:1305
|
0.032x |
|
China MeiDong Auto Holdings Limited
PINK:CMEIF
|
0.135x |
Annual Cash Flow Conversion Efficiency for Compugen (1999–2024)
The table below shows the annual cash flow conversion efficiency of Compugen from 1999 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $54.91 Million | $49.60 Million | 0.903x | +265.02% |
| 2023-12-31 | $65.56 Million | $-35.89 Million | -0.547x | -25.35% |
| 2022-12-31 | $77.68 Million | $-33.92 Million | -0.437x | -100.66% |
| 2021-12-31 | $106.69 Million | $-23.22 Million | -0.218x | +7.95% |
| 2020-12-31 | $119.78 Million | $-28.32 Million | -0.236x | +67.51% |
| 2019-12-31 | $38.32 Million | $-27.89 Million | -0.728x | -103.92% |
| 2018-12-31 | $37.24 Million | $-13.29 Million | -0.357x | +65.90% |
| 2017-12-31 | $29.30 Million | $-30.66 Million | -1.046x | -235.38% |
| 2016-12-31 | $63.52 Million | $-19.82 Million | -0.312x | -9.54% |
| 2015-12-31 | $89.90 Million | $-25.61 Million | -0.285x | -170.78% |
| 2014-12-31 | $105.97 Million | $-11.15 Million | -0.105x | +47.90% |
| 2013-12-31 | $31.89 Million | $-6.44 Million | -0.202x | +67.10% |
| 2012-12-31 | $17.67 Million | $-10.85 Million | -0.614x | -29.93% |
| 2011-12-31 | $19.58 Million | $-9.25 Million | -0.472x | -212.23% |
| 2010-12-31 | $28.29 Million | $-4.28 Million | -0.151x | +44.39% |
| 2009-12-31 | $27.40 Million | $-7.45 Million | -0.272x | +72.82% |
| 2008-12-31 | $10.00 Million | $-10.01 Million | -1.001x | -105.79% |
| 2007-12-31 | $17.29 Million | $-8.41 Million | -0.486x | -26.03% |
| 2006-12-31 | $25.74 Million | $-9.93 Million | -0.386x | -25.94% |
| 2005-12-31 | $36.25 Million | $-11.11 Million | -0.306x | -24.48% |
| 2004-12-31 | $49.57 Million | $-12.20 Million | -0.246x | -164.19% |
| 2003-12-31 | $59.81 Million | $-5.57 Million | -0.093x | +29.28% |
| 2002-12-31 | $68.88 Million | $-9.08 Million | -0.132x | -11.08% |
| 2001-12-31 | $80.06 Million | $-9.50 Million | -0.119x | -78.69% |
| 2000-12-31 | $92.51 Million | $-6.14 Million | -0.066x | +85.27% |
| 1999-12-31 | $12.79 Million | $-5.76 Million | -0.451x | -- |